This book presents the basics of schizophrenia, drug targets for this disease, and potential for new drugs and therapeutics. The book begins with a discussion of prevalence and etiology, and then describes therapies like dopamine agonists and PDE inhibitors and the rise of interest in adderssing untreated symptoms. Subsequent chapters discuss receptor modulators, inhibitors, and targetting strategies for drug discovery. Within these chapters, the authors focus on each major pharmacological target and address both the neurobiological and chemical aspects of that target.
